M. Carmona-García

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

M. Piccart, M. Filetti, R. Salazar, 2022, The Lancet Oncology.

Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.

R. Salazar, F. Mazzoni, N. Harbeck, 2021, JAMA oncology.

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

M. Filetti, R. Salazar, A. Maconi, 2022, European Journal of Cancer.

Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study.

C. Castro, K. Innos, M. Sant, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

M. Piccart, M. Filetti, F. Grosso, 2023, The Lancet Oncology.

Multimorbidity by Patient and Tumor Factors and Time-to-Surgery Among Colorectal Cancer Patients in Spain: A Population-Based Study

María-José Sánchez, M. Rodríguez-Barranco, R. Marcos-Gragera, 2020, Clinical epidemiology.

Multimorbidity and short-term overall mortality among colorectal cancer patients in Spain: A population-based cohort study.

María-José Sánchez, M. Rodríguez-Barranco, E. Salamanca-Fernández, 2020, European journal of cancer.

318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

Carlo, Gennari, Provenzano, 2020, Annals of Oncology.